Literature DB >> 14874519

C-reactive protein in the chronic rheumatic diseases.

A G S HILL.   

Abstract

Entities:  

Keywords:  BLOOD PROTEINS; RHEUMATISM/blood in

Mesh：

Substances：

Year:  1951        PMID： 14874519     DOI： 10.1016/s0140-6736(51)91595-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Laboratory aids in steroid therapy.

Authors:  J H GLYN
Journal:  Ann Rheum Dis       Date:  1956-12       Impact factor: 19.103

2.  [Clinical studies on acute phase protein (C-reactive protein)].

Authors:  H BAUER; D SEITZ
Journal:  Klin Wochenschr       Date:  1953-04-01

3.  Differential diagnosis of fever in systemic lupus erythematosus using discriminant analysis.

Authors:  T Inoue; T Takeda; S Koda; N Negoro; M Okamura; K Amatsu; M Kohno; T Horiguchi; Y Kanayama
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

4.  The behavior of a newly described acute-phase protein in inflammatory joint disease.

Authors:  M L Schwartz; W A Andiman; R H Gifford; A Schluederberg
Journal:  Inflammation       Date:  1976-06       Impact factor: 4.092

5.  C-reactive protein and serological indices of disease activity in systemic lupus erythematosus.

Authors:  J V Bertouch; P J Roberts-Thompson; P H Feng; J Bradley
Journal:  Ann Rheum Dis       Date:  1983-12       Impact factor: 19.103

6.  C-reactive protein (CRP) levels in systemic lupus erythematosus (SLE).

Authors:  L F Linares; J J Gomez-Reino; P E Carreira; L Morillas; I Ibero
Journal:  Clin Rheumatol       Date:  1986-01       Impact factor: 2.980

7.  C-reactive protein in childhood dermatomyositis.

Authors:  R H Haas; R F Dyck; V Dubowitz; M B Pepys
Journal:  Ann Rheum Dis       Date:  1982-10       Impact factor: 19.103

8.  Acute phase protein changes in antigen-induced mono-articular arthritis in rabbits and mice.

Authors:  I M Hunneyball; M Spowage; M J Crossley; I F Rowe; M L Baltz
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.